Tom Herzog, chief operating officer of Netsmart, says that “digitization has always been about entering data into the system” and that users are asking, “What does the system do for me?” It’s time to…
Continue Reading
Nanox’s HealthFLD, an AI-powered software, has received FDA clearance for automated analysis of liver attenuation from CT scans. This breakthrough technology facilitates early detection of fatty liver, aiding clinicians in diagnosing metabolic diseases. With…
Continue Reading
The Platform Offers Comprehensive, Tailored Threat Intelligence and Risk Assessment, Empowering Hospitals and Health Systems to Protect Patient Data with Precision
Health2047, a Silicon Valley-based venture studio founded by the American Medical Association (AMA), today…
What You Should Know:
– Samsung’s Galaxy Watch has received De Novo authorization from the US Food and Drug Administration (FDA) for its sleep apnea detection feature.
– This marks a significant step forward in wearable…
Continue Reading
Background: The Health eLiteracy for Prevention in General Practice trial is a primary health care–based behavior change intervention for weight loss in Australians who are overweight and those with obesity from lower socioeconomic areas….
Continue Reading
What You Should Know:
– Persistent Systems, a leading digital engineering and enterprise modernization company, and Microsoft today announced the launch of an innovative Generative AI-powered Population Health Management (PHM) Solution. This collaborative effort aims…
Continue Reading
Moderate-risk medical devices constitute 99% of those that have been regulated by the U.S. Food and Drug Administration (FDA) since it gained authority to regulate medical technology nearly five decades ago. This article presents…
Continue Reading
Elissa Toder, MBA, VP of Quality Improvement Strategy & Solutions at Reveleer
In the ongoing transition to value-based care (VBC), provider contracting poses challenges for health plans and providers. In my past role as the…
Continue Reading
Hematoma expansion (HE) is a modifiable risk factor and a potential treatment target in patients with intracerebral hemorrhage (ICH). We aimed to train and validate deep-learning models for high-confidence prediction of supratentorial ICH expansion,…
Continue Reading
GE HealthCare received FDA 510(k) clearance for its Novii+ maternal and fetal monitoring solution, which will become available to U.S. customers later in the year.The device, consisting of a wearable and wireless sensor, enables…
Continue Reading
